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ttp://dx.doi.org/10.1016/j.ajpath.2013.04.024Glomerular injury leads to podocyte loss, a process directly underlying progressive glomerular scarring and
decline of kidney function. The inherent repair process is limited by the inability of podocytes to regen-
erate. Cells of renin lineage residing alongside glomerular capillaries are reported to have progenitor
capacity. We investigated whether cells of renin lineage can repopulate the glomerulus after podocyte
injury and serve as glomerular epithelial cell progenitors. Kidney cells expressing renin were genetically
fate-mapped in adult Ren1cCreERRs-tdTomato-R, Ren1cCreRs-ZsGreen-R, and Ren1dCreZ/EG reporter
mice. Podocyte depletion was induced in all three cell-speciﬁc reporter mice by cytotoxic anti-podocyte
antibodies. After a decrease in podocyte number, a signiﬁcant increase in the number of labeled cells
of renin lineage was observed in glomeruli in a focal distribution along Bowman’s capsule, within the
glomerular tuft, or in both locations. A subset of cells lining Bowman’s capsule activated expression of the
glomerular parietal epithelial cell markers paired box protein PAX2 and claudin-1. A subset of labeled cells
within the glomerular tuft expressed the podocyte markers Wilms tumor protein 1, nephrin, podocin, and
synaptopodin. Neither renin mRNA nor renin protein was detected de novo in diseased glomeruli. These
ﬁndings provide initial evidence that cells of renin lineage may enhance glomerular regeneration by
serving as progenitors for glomerular epithelial cells in glomerular disease characterized by podocyte
depletion. (Am J Pathol 2013, 183: 542e557; http://dx.doi.org/10.1016/j.ajpath.2013.04.024)Supported in part by NIH grants R01-HL048459 R21-CA121212, and
P30-CA016056 (K.G.); R01 DK87389, RC1 DK84077, and R24 DK94768
(J.S.D.); and R01-DK056799 and R21-DK081835 (SJS).Glomerular diseases are the leading cause of progressive
chronic and end-stage kidney disease.1 Recent studies have
demonstrated important roles for both podocytes and parietal
epithelial cells (PECs) in these diseases. Diabetic neph-
ropathy,2e5 membranous nephropathy,6 and classical focal
segmental glomerulosclerosis (FSGS)7e10 are characterized
by loss of podocytes. The conventional paradigm has been
that, when podocyte number decreases after disease-induced
injury, podocytes cannot replace themselves because they are
terminally differentiated cells and cannot proliferate.11e17
This inadequate regeneration of podocytes directly under-
lies the development of progressive glomerulosclerosis and
reduced kidney function.2,4,6,7,10,18e20 Recent studies have
challenged this conventional paradigm, showing thatstigative Pathology.
.podocyte number can be restored under certain circum-
stances.21e23 Importantly, this occurs in the absence of
podocyte proliferation,22 suggesting that there may be one or
more podocyte progenitors.
Several seminal studies have shown that the neighboring
glomerular PECs might serve this role.24e28 After podocyte
loss, PECs activate expression of proteins considered to be
restricted to podocytes.24,29,30 Such cells may be in transition,
because they express both PEC and podocyte proteins, and
have therefore been called glomerular epithelial transition
Renin Lineage Cell and Glomerular Repaircells.24,29,30 The number of glomerular epithelial transition
cells detected lining Bowman’s capsule and within the
glomerular tuft increases in membranous nephropathy,30
classical FSGS,30 and aging nephropathy.29 Based on these
various studies, a new paradigm has emerged, that in protei-
nuric glomerular diseases characterized by reduced podocyte
number subpopulations of PECs express podocyte markers
and migrate to the glomerular basement membrane.31e33
Progenitor cells are oligopotent cells that frequently lie
dormant in the tissue inwhich they reside; however, after local
injury or death of mature, functioning cells, they replace the
lost cell or cells by transdifferentiating into a new type of cell,
acquiring its ultrastructure, activating transcriptional
programs unique to those cells, and performing the biological
functions of those cells. Although recent studies indicating
that PECs may become podocytes are convincing, it remains
to be shown that PECs become fully functional podocytes.
Previous studies have identiﬁed the juxtaglomerular
compartment (JGC) as a reservoir of kidney progenitors.34,35
In adults, juxtaglomerular granular cells are modiﬁed smooth
muscle cells (also called myoepithelioid-like cells) present in
the vascular component of the juxtaglomerular apparatus, at
the distal end of afferent arterioles and, to a lesser extent, of the
efferent arterioles.36 These cells are the major source of total
renin production and circulating active renin37,38 and there-
fore play critical roles in the regulation of vascular tone and
the renineangiotensinealdosterone system.39 An elegant
study showed that cells of renin lineage can also serve
a progenitor function for smooth muscle, epithelial, mesan-
gial, and extrarenal cells and can be detected in low numbers
in normal glomeruli.34 Moreover, we have previously shown
that nonerenin-expressing cells of the extraglomerular
mesangium,36 residing in the JGC, repopulate the glomerular
tuft and restore mesangial cell number after mesangiolysis in
a model of mesangioproliferative glomerulonephritis.35
The purpose of these studies was to apply genetic cell
fate-mapping strategies in four transgenic geneetargeted
mice that report for cells of renin lineage to test the
hypothesis that these cells serve as progenitor cells for
podocytes and PECs during experimental glomerular
disease characterized by a decrease in podocyte number.
Three newly generated renin-reporter mouse strains and one
existing reporter mouse strain were used.Materials and Methods
Reporter Mice
Four different reporter mouse strains were used to geneti-
cally fate-map cells of renin lineage, three of which were
newly generated.
Ren1cCreERRs-tdTomato-R
The newly generated Ren1cCreERRs-tdTomato-R mouse
labels the Ren1c gene with tomato red protein only after the
administration of tamoxifen (Sigma-Aldrich, St. Louis, MO).The American Journal of Pathology - ajp.amjpathol.orgBecause renin expression might be switched on later in life,
thus confounding the data from the constitutive reporter mice,
we introduced a Cre recombinase fused to the human estrogen
receptor (ER) ligand-binding domain40 into exon 1 of the
Ren1c gene residing within a 240-kb bacterial artiﬁcial chro-
mosome (BAC), here represented as RenCreER, using previ-
ously described methods41,42 (Supplemental Figure S1). The
Ren1cCreER transgenic line, when crossed to the reporter
Gt(ROSA)Sortm9(CAG-tdTomato)Hze/J,43 allows for the permanent
tagging of cells of renin lineage with tomato red protein, which
is detected by red ﬂuorescent protein (RFP), within temporal
windows deﬁned by treatment with tamoxifen (Supplemental
Figure S2A). Accordingly, 5-week-old bigenic mice, weigh-
ing 16 to 20 g, were given either 100 mg/kg tamoxifen or
vehicle by intraperitoneal injection on alternate days for 6 days.
Ren1cCreRs-ZsGreen-R
The newly generated Ren1cCreRs-ZsGreen-R reporter
mouse labels the Ren1c gene with ZsGreen. To tag cells of
renin lineage indeﬁnitely, even after renin is no longer being
transcribed, a Cre-recombinase cassette40 was cloned into the
Ren1c BAC using homologous recombination, as described
previously42,43 (Supplemental Figure S1). The renin regula-
tory region can then control Cre recombinase, which recog-
nizes and excises loxP sites in DNA. When the Ren1cCre
transgenic line is crossed with the commercially available
B6.Cg-Gt(ROSA)26Sortm6(CAG-ZsGreen1)Hze/J reporter mouse,43
here represented as ZsGreen, a ﬂoxed stop cassette is excised,
allowing for constitutive ZsGreen expression driven by
a CAG promoter. Validation of the ﬁdelity of this newly
generated Ren1cCreRs-ZsGreen-R transgenic mouse in
reporting cells of renin lineage was conﬁrmed by visualizing
adult kidney tissue (Supplemental Figure S2B). Ren1cCre
Rs-ZsGreen-R mice devoid of Cre were used as negative
controls for labeling.
Ren1dCreZ/EG
The existing Ren1dCreZ/EG reporter mouse labels the
Ren1d gene with GFP, as previously reported.34 The utility
of this knock-in mouse is that all cells of renin lineage and
their descendants permanently express GFP, even if renin
expression is subsequently decreased or absent.44 Mice with
Cre recombinase under control of the renin locus34 were
crossed with Z/EG reporter mice.44 Z/EG reporter mice
constitutively express lacZ under the control of the CMV
enhancer/chicken actin promoter. When crossed with a Cre
recombinase-expressing strain, lacZ expression is replaced
with enhanced GFP expression in tissues expressing Cre.
RenGFP
The newly generated RenGFP reporter mouse serves to
report renin promoter activity by the presence of a GFP
reporter; that is, when renin is transcribed, GFP is
expressed. Thus, to more comprehensively ensure control of
reporter expression, homologous recombination was used to
introduce a GFP cassette into exon one of the Ren1c gene543
Pippin et alresiding within a 240-kb BAC to generate a construct that
has GFP expression controlled from within the entire natural
genomic sequence context for renin (Supplemental
Figure S1). The insertion of GFP into the renin gene,
which is centrally located within the BAC, allows large
amounts of 50- and 30-ﬂanking sequence to act on reporter
expression. This is done in an effort to gain a more faithful
representation of endogenous renin gene expression, as well
as to insulate transgene expression from inﬂuences of
surrounding sequence at the insertional site. The integration
of GFP into the renin containing BAC to generate the
RenGFP transgenic line has been described previously.42
Experimental Focal Segmental Glomerulosclerosis
Model
Disease Model
The goal of these studies was to test the hypothesis that cells
of renin lineage are progenitors for glomerular epithelial
cells in glomerular disease characterized by an abrupt
decline in podocyte number. Accordingly, an inducible
model of experimental glomerular disease resembling
classic clinical FSGS was induced with a cytotoxic antibody
in all four strains of mice. We have previously reported that
this experimental FSGS model induces an abrupt decline in
podocyte number, which is associated clinically with the
onset of proteinuria and histologically with focal and
segmental glomerulosclerosis.30,45,46 This is not a model of
crescentic glomerulonephritis, nor of podocyte proliferation,
which is induced by a different antibody (as we have
previously reported13,47e50).
Antibodies
Polyclonal antibodies were generated by immunizing sheep
with whole rabbit glomeruli in Freund’s adjuvant (Sigma-
Aldrich). Antiserumwas heat inactivated; IgGwas isolated by
caprylic acid (Sigma-Aldrich) precipitation of serumproteins.
The retained IgG was then dialyzed against PBS sterile
ﬁltered.51 When injected, sheep anti-rabbit glomerular anti-
bodies bind selectively to podocytes. This was veriﬁed by
double-staining for sheep IgG deposition within the glomer-
ulus and for the podocyte-speciﬁc proteins nephrin and syn-
aptopodin. Sheep IgG staining in the glomerulus overlaps
extensivelywith staining for both podocyte proteins, and does
not bind to other cells in the glomerulus or beyond
(Supplemental Figure S3). Antibody binding to podocytes
induces rapid nonecomplement-mediated podocyte
apoptosis and necrosis, leading to reduced podocyte number,
proteinuria, and segmental glomerular scarring in fewer than
50% of glomeruli.30,45,46 Disease was induced in all four
reporter mice by administering 12.5 mg/20 g body weight
sheep anti-rabbit glomerular antibodies (two intraperitoneal
injections, 24 hours apart), as previously reported.30,45,46
There was an increased incidence of mortality within
24 hours of antibody administration in the Ren1cCreER
Rs-tdTomato-R mouse strain. The dose was therefore544decreased to 10 mg/20 g body weight (two intraperitoneal
injection, 24 hours apart) in thesemice. Control mice received
vehicle only.
Time Points
The time points studied for each reporter strain after
induction of experimental FSGS (Supplemental Figure S4)
were as follows.
At 49 days after the last tamoxifen injection, a survival
kidney biopsy was performed on all Ren1cCreERRs-
tdTomato-R mice, to ensure that cells of renin lineage were
labeled in individual mice given tamoxifen, but not in
control mice. This biopsy specimen, weighing <3.5% of
total kidney mass, served as the baseline (day 0) for each
mouse. After the mice had recovered from surgery, disease
was induced in all mice as described above. Diseased male
and female Ren1cCreERRs-tdTomato-R mice aged 13
weeks were then sacriﬁced at day 7 (n Z 5 per group) and
day 14 (n Z 5 per group) of disease. Male and female
Ren1cCreRs-ZsGreen-R mice, aged 5 to 20 weeks, were
sacriﬁced at day 0 (nZ 3), day 3 (nZ 3), day 7 (nZ 3), or
day 14 (nZ 4) of disease.52 Male and female Ren1dCreZ/
EG mice, aged 8 to 15 weeks, were sacriﬁced at day
0 (n Z 2), day 7 (n Z 3), or day 14 (n Z 3) of disease.
Male and female RenGFP mice, aged 9 to 13 weeks, were
sacriﬁced at day 0 (nZ 6), day 14 (nZ 3), day 21 (nZ 3),
or day 28 (n Z 3) of disease.
Ethics
Experimental protocols were approved by the Animal Care
committees of the University of Washington, Roswell Park
Cancer Institute, Duke University Medical Center, and
Durham Veterans Affairs Medical Center. All animal
procedures were conducted in accordance with the respec-
tive Institutional Animal Care and Use Committee.
Immunostaining
Verifying Podocyte Speciﬁcity of Cytotoxic Antibody
To verify the binding of injected sheep anti-glomerular anti-
body to podocytes within the glomerulus, double-
immunoﬂuorescence staining for sheep IgG and nephrin or
synaptopodin was performed. Rabbit anti-sheep IgG H&L
(FITC) polyclonal antibody (Abcam, Cambridge, MA),47
guinea pig anti-nephrin polyclonal antibody (Fitzgerald
Industries, Concord, MA), and mouse anti-synaptopodin
monoclonal antibody (Fitzgerald Industries) were used.
Nephrin and synaptopodin were visualized with Alexa Fluor
594 (Life TechnologieseInvitrogen, Carlsbad, CA).
Identifying Cells of Renin Lineage
Cells of renin lineage were identiﬁed by inducible genetic
fate mapping in Ren1cCreERRs-tdTomato-R mice by
RFP and by genetic fate mapping in Ren1dCreZ/EG mice
with GFP, in Ren1cCreRs-ZsGreen-R mice with ZsGreen,ajp.amjpathol.org - The American Journal of Pathology
Renin Lineage Cell and Glomerular Repairand in RenGFP mice with GFP. To detect RFP and GFP,
kidney biopsy specimens were ﬁxed in neutralized formalin
(Globe Scientiﬁc Inc., Paramus, NJ) and embedded in
parafﬁn. For ZsGreen, kidneys were perfusion-ﬁxed with
4% paraformaldehyde (Electron Microscopy Sciences,
Hatﬁeld, PA) in 0.1 mol/L phosphate buffer, pH 7.4, fol-
lowed by immersion ﬁxation for 60 minutes. Antibodies
were not needed to detect ZsGreen alone or RFP alone.
Immunoﬂuorescence staining for RFP and GFP was per-
formed on 4-mm-thick sections, as previously reported.30,53
Determining Whether Cells of Renin Lineage Express
Glomerular Cell Markers
We next determined whether labeled cells of renin lineage
begin to express proteins considered to be unique to different
glomerular cell types. Immunoﬂuorescence double-staining
was performed as we have previously reported54e56 for the
cell of renin lineage reporters RFP, GFP, or ZsGreen with
proteins considered to be speciﬁc for the podocyte markers
WT-1, synaptopodin, and podocin (Abcam), as well as for
PECs [PAX2 (Invitrogen, Carlsbad, CA) and claudin-1
(Zymed Laboratories, San Francisco, CA)], mesangial cells
[PDGFR-b (R&D Systems Inc., Minneapolis, MN) and type
IV collagen (Southern Biotechnology Associates, Inc., Bir-
mingham, AL)], and glomerular endothelial cells (MECA-32;
Novus Biologicals, Littleton, CO).
Measuring Podocyte Number
Because of concerns that WT-1 is not a reliable podocyte-
speciﬁc protein, we used p57 staining to measure podocyte
number. A previously published analysis comparing p57,
WT-1, and podocyte-speciﬁc reporter mice substantiated the
use of p57 to determine podocyte number.50 Immunostaining
for p57 was performed with a rabbit p57 primary antibody
(Santa Cruz Biotechnology, Santa Cruz, CA) and then with
a biotin-conjugated mouse anti-rabbit secondary antibody
(Jackson ImmunoResearch Laboratories, West Grove, PA).
Measuring Renin Protein Expression
To ensure that renin protein expression was conﬁned to cells
in the JGC, and that renin expression did not occur in
glomeruli de novo during disease, double-staining was
performed for the reporters GFP, ZsGreen, and RFP with
renin (biotinylated sheep antibody to renin; Innovative
Research, Novi, MI), as described above.
Identifying Stem Cell Markers
Staining was performed for three markers that are consid-
ered markers of stem cells: CD24, CD44, and CD133 (all
antibodies from Abcam).
Controls
Positive controls consisted of kidney tissue (from
Ren1dCreZ/EG and Ren1cCreRs-ZsGreen-R mice with
and without disease) known to be positive for the proteins
being stained. Immunostaining for renin,57 PAX2,58 claudinThe American Journal of Pathology - ajp.amjpathol.org1,59 WT-1,60 synaptopodin,61 GFP,62 and p5763 with the
antibodies used in these studies has been veriﬁed previously.
For negative controls, the primary antibody was omitted or
Ren1dCreZ/EG or Ren1cCreRs-ZsGreen-R mice devoid
of Cre were used.
Quantiﬁcation of Immunostaining
The number of cells expressing reporter alone and the number
of cells double-staining for reporter and PAX2, claudin-1,
WT-1, or synaptopodin were counted per glomerular cross
section. An average of 76  16 glomeruli from each animal
were assessed for each strain. These cell numbers are pre-
sented as means  SEM. One-way analysis of variance was
calculated, and P < 0.05 was considered signiﬁcant.
Assessment of Glomerular Injury
Glomerulosclerosis was measured and quantiﬁed on PAS-
stained sections, as we have described previously.50,64,65 An
average of 50  10 glomeruli in each animal was graded
quantitatively, as follows. Grade 0 was deﬁned as 0%
glomerular tuft area involvement (normal glomerulus with no
abnormalities); grade 1, <1% to 25% (a few capillaries with
dilation); grade 2, <26% to 50% (multiple capillaries with
dilation); grade 3, <51% to 75% (multiple capillaries with
dilation and some synechial attachments); and grade 4,<76%
to 100% (multiple synechial attachments with focal segmental
sclerosis).
Results
Characterization of Ren1cCreERRs-tdTomato-R Mice
To ensure that the presence of labeled cells within the
glomerulus was not due to increased de novo renin expression
during disease, we generated Ren1cCreERRs-tdTomato-R
mice, in which permanent labeling of renin-producing cells
with the tdTomato Red reporter was induced in adult mice
within speciﬁc temporal windows deﬁned by administration of
tamoxifen, thus allowing the fate of only these cells to be
mapped. In normal Ren1cCreERRs-tdTomato-R mice given
tamoxifen, staining for the tdTomato Red reporter with RFP
antibody was detected only in cells restricted to the JGC; no
labeled cellswere detected in glomeruli (Figure 1,B andD).No
staining for the reporter was detected when only vehicle was
given (Figure 1, A and C). In normal mice, renin staining was
restricted to cells in the JGC; no renin staining was detected in
the glomeruli. These results validate the feasibility of geneti-
cally inducible fatemapping inRen1cCreERRs-tdTomato-R
mice to permanently label cells of renin lineage.
Cells of Renin Lineage Appear in Glomeruli of
Ren1cCreERRs-tdTomato-R Mice with Experimental
FSGS
After administration of the cytotoxic anti-podocyte antibody
to induce experimental FSGS, sheep IgG staining was in545
Figure 1 Characterization of adult Ren1cCreERRs-tdTomato-R mice.
Double-staining was performed for renin protein (red) and for the reporter
for cells of renin lineage using a ﬂuorescein-conjugated antibody to RFP
(green). A merge of the two appears yellow. A: In baseline (day 0) mice not
given tamoxifen, renin staining was restricted to the JGC (arrows). The
boxed region is shown at higher magniﬁcation in the inset. Staining for
the reporter was not detected. B: In baseline mice given tamoxifen, the
majority of renin-staining cells costained for RFP (white; dashed arrows),
and these costaining cells were conﬁned to the JGC. Occasional JGC cells
only stained for renin (arrow). The boxed region is shown at higher
magniﬁcation in the inset, where costaining JGC are more clearly seen. C:
In diseased Ren1cCreERRs-tdTomato-R mice not given tamoxifen (day
14), renin staining was restricted to the JGC (arrows). The boxed region is
shown at higher magniﬁcation in the inset, where renin staining is seen to
be restricted to the JGC. Staining for RFP was not detected. D: In diseased
mice given tamoxifen (day 14), renin staining was restricted to the JGC and
costained with RFP (white; dashed arrow). The boxed region is shown at
higher magniﬁcation in the inset, where costaining JGC are more clearly
seen. No renin was detected in the diseased glomerulus. A labeled cell of
renin lineage in the glomerulus stains green (thick arrow). Original
magniﬁcation: 100 (main images); 630 (insets).
Figure 2 Cells of renin lineage are present in glomeruli of Ren1cCreER
Rs-tdTomato-R mice with experimental FSGS. Ren1cCreERRs-tdTomato-R
mice were given tamoxifen for three alternate days to temporally and
permanently label only cells of renin lineage. A survival biopsy was then
performed (baseline, day 0), after which experimental FSGS was induced
in each mouse. A: At day 0, labeled cells of renin lineage reporter (red)
were restricted to the JGC (arrows). No labeled cells were detected in
individual glomeruli (circles). B: A higher magniﬁcation view of the
boxed region in panel A shows reporter-labeled cells of renin lineage in
the JGC (arrow) but not within the glomerulus (circle). C: At day 14 of
disease, reporter-labeled cells were detected in the JGC (thick arrows)
and in a glomerulus (thin arrows). Labeled cells within glomeruli were
focal in nature; ﬂuorescence was absent in two glomeruli (circles). D: A
higher magniﬁcation view of the boxed region in panel C shows reporter-
labeled cells in the JGC (thick arrow) and within the glomerulus (thin
arrows). E: At day 14 of disease, reporter-labeled cells were detected in
the JGC (thick arrows) and in the glomerulus (thin arrows). F and G:
Higher magniﬁcation views of the two boxed regions in panel E show
reporter-labeled cells in the JGC (thick arrow) and within the glomerulus
(thin arrows). Original magniﬁcation: 100 (A, C, and E); 630 (B, D,
F, and G).
Pippin et ala typical podocyte distribution, and was not detected in
PECs or in the JGC (Supplemental Figure S5A). In diseased
Ren1cCreERRs-tdTomato-R mice, podocyte number,
measured by p57 staining,50 decreased relative to baseline
(10.5  0.45) by 32% at day 7 and by 33% at day 14 (7.1 
0.49 and 7.0  0.56, respectively), (P < 0.001)
(Supplemental Figure S5B). At days 7 and 14, however, the
disease was focal, and typically between 10% and 40%
of glomeruli had histological evidence of disease as previ-
ously shown.50,64 These data show that experimental FSGS
was induced in Ren1cCreERRs-tdTomato-R mice.546Cells of renin lineage, identiﬁed by the RFP reporter, were
present in diseased glomeruli (Figure 2). After tamoxifen
administration but before disease induction, a survival kidney
biopsy was performed on all mice to ensure labeling; these
biopsy data served as the baseline for individual mice. Labeled
cells of renin lineage were restricted to the JGC in baseline
survival kidney biopsy specimens. After disease induction,
however, labeled cells of renin origin were detected in 13.8 
1.16%of glomeruli at day7 and in14.8 1.78%of glomeruli at
day 14 (both P < 0.0001 versus baseline) (Figure 2 and
Supplemental Figure S5). In these focally involved glomeruli,
labeled cells were detected either within the glomerular tuft or,
to a lesser extent, along Bowman’s capsule. Although reporter
cells were detected in 14% to 15% of glomeruli, renin staining
was localized to the cells outside the glomerulus; no de novo
renin staining was detected within glomeruli of diseased mice
(Figure 1). These data show that cells of renin lineage labeled
with tomato redprotein andderived from the JGCweredetected
de novo in glomeruli of diseased mice, and that these cells no
longer expressed renin when located within the glomerulus.ajp.amjpathol.org - The American Journal of Pathology
Figure 3 Cells of renin lineage express proteins considered to be
podocyte-speciﬁc in glomeruli of Ren1cCreERRs-tdTomato-R mice with
experimental FSGS. Double-staining was performed for WT-1, nephrin, or
podocin (red), and for the cells of renin lineage reporter with a ﬂuorescein-
conjugated antibody to RFP (green). A: Staining for WT-1 (red; thin arrows)
was conﬁned to the glomerular tuft at baseline (day 0). Staining for RFP was
conﬁned to the JGC (green; thick arrows). Red blood cell autoﬂuorescence
(yellow-orange) was noted in the glomerular tuft. B: Costaining for WT-1 and
RFP (yellow-orange; thick dashed arrows) in three cells within the glomerulus
at day 14 of disease. One reporter-labeled cell in the glomerulus did not costain
for WT-1 (thin dashed arrow). Most glomerular cells stained for WT-1 alone
(red; thin arrows). C: A highermagniﬁcation viewof theboxed region in panel
B. D: Staining for nephrin (red; thin arrows) was conﬁned to the glomerular
tuft at baseline (day 0). Staining for RFP was conﬁned to the JGC (green; thick
arrow). E: Costaining for nephrin and RFP (yellow-orange; dashed arrow)
within the glomerulus at day 14 of disease. An RFP-labeled cell outside the
glomerulus did not costain with nephrin (thick arrow). Ribbon-like Nephrin
staining alone (red; thin arrow). F: A higher magniﬁcation view of the boxed
region in panel E. G: Staining for podocin (red; thin arrows) was conﬁned to
the glomerular tuft at baseline (day 0). Staining for RFPwas conﬁned to the JGC
(green; thick arrow). H: Costaining for podocin and RFP (yellow-orange;
dashed arrow) within the glomerulus at day 14 of disease. An RFP-labeled cell
outside the glomerulus did not costain with podocin (thick arrow). Cyto-
plasmic podocin staining alone (red; thin arrow). I: A higher magniﬁcation
view of the boxed region in panelH. These representative examples show that
a subset of cells of renin lineage that have entered the glomeruli of diseased
Ren1cCreERRs-tdTomato-R mice begin to express WT-1, nephrin, and podo-
cin, all ofwhichare considered to be podocyte proteins. Originalmagniﬁcation:
400 (A, B, D, E, G, and H); 1000 (C, F, and I).
Renin Lineage Cell and Glomerular RepairCells of Renin Lineage within Glomeruli of Ren1cCreER
Rs-tdTomato-R Mice with Experimental FSGS Express
Proteins Considered Speciﬁc to Podocytes and PECs
Podocyte Proteins
Having identiﬁed cells of renin lineage in glomeruli of diseased
Ren1cCreERRs-tdTomato-R mice, we investigated whether
these cells begin to express glomerular epithelial cell proteins.
We performed double-staining for the renin lineage reporter
and for three proteins traditionally considered to be podocyte
speciﬁc: the transcriptional regulatorWT-1, the transmembrane
IgG superfamily protein nephrin, and the stomatin family
protein podocin. Staining for the reporter and these podocyte
proteins did not overlap in mice at baseline (they were in
different kidney compartments).At days7 and14, however, the
staining for the reporter and WT-1, nephrin, and podocin
overlapped in glomeruli in diseased animals (Figure 3 and
Supplemental Figure S6). The number of cells positive for both
RFP andWT-1 represented 50 10%of theRFP-positive cells
in the glomerular tuft at day 14of disease (0.074 0.02double-
positive cells per glomerular cross section in disease versus 0 at
baseline). Cells double-positive for both RFP and nephrin, or
both RFP and podocin, represented 30  8% of the RFP-
positive cells in the glomerular tuft at day 14 of disease (0.04
 0.01 double-positive cells per glomerular cross section in
disease versus 0 at baseline).
In both instances, labeled cells of renin lineage were typi-
cally detected in segments of glomeruli in which podocytes
were depleted (as assessed by reduced WT-1, nephrin, or
podocin staining), regardless of whether they coexpressed the
marker protein.
Parietal Epithelial Cell Proteins
Double-staining was also performed for the renin lineage
reporter and the nuclear transcription factor PAX2 or the tight
junction protein claudin-1, both of which are expressed in
glomerular PECs (Figure 4 and Supplemental Figure S7). At
baseline before disease induction, staining for the reporter and
the PECmarkers did not overlap. In contrast, at days 7 and 14
of disease, overlapping staining was detected for the reporter
and both PAX2 and claudin-1 in the majority (but not all) of
the labeled cells in the glomerulus. Cells double-positive for
both RFP and PAX2 or claudin-1 represented 60 5% of the
RFP-positive cells lining Bowman’s capsule at day 14 of
disease (0.03  0.008 double-positive cells per glomerular
cross section in disease versus 0 at baseline).
Taken together, these data show that a subset of cells
of renin lineage begin to express podocyte proteins and
PEC proteins when in a glomerular location in diseased
Ren1cCreERRs-tdTomato-R mice.
Podocyte Number Decreases in Ren1cCreRs-ZsGreen-R
Mice with Experimental FSGS
To corroborate these ﬁndings, experimental FSGS was
induced in Ren1cCreRs-ZsGreen-R mice, in which cellsThe American Journal of Pathology - ajp.amjpathol.orgof renin lineage were labeled permanently by the Anthozoa
coral reef protein ZsGreen.66 After the onset of disease,
podocyte number (as judged by p57 immunostaining)
decreased progressively relative to the baseline level547
Figure 4 Cells of renin lineage express glomerular PEC proteins in
glomeruli of Ren1cCreERRs-tdTomato-R mice with experimental FSGS.
Double-staining was performed for PEC proteins with antibodies to PAX2 or
claudin-1 (red) and for the cells of renin lineage reporter with a ﬂuores-
cein-conjugated antibody to RFP (green). A: At baseline (day 0) staining
for PAX2 (thin arrows) was conﬁned to Bowman’s capsule, and did not
overlap with staining for the reporter (thick arrow) restricted to the JGC.
B: At day 14 of disease, a subset of cells lining Bowman’s capsule within
the glomerulus costained for PAX2 and the reporter (yellow; thick arrow).
Other PAX2-staining cells did not costain with the reporter (thin arrows).
C: A higher magniﬁcation view of the boxed region in panel B. D: In
baseline mice, staining for claudin-1 (red; thin arrows) did not overlap
with staining for the reporter (green; thick arrow), which was conﬁned to
the JGC. E: In diseased mice, RFP-labeled cells were detected lining Bow-
man’s capsule; these cells costained for claudin-1 (yellow-orange; thick
arrow). Staining for claudin-1 alone (red; thin arrows). Red blood cell
autoﬂuorescence (light green) was noted in the glomerular tuft. F: A higher
magniﬁcation view of the boxed region in panel E. These representative
examples show that, in diseased Ren1cCreERRs-tdTomato-R mice, a subset
of cells of renin lineage that line Bowman’s capsule express the PEC
proteins PAX2 and claudin-1.
Pippin et al(11.2  0.29) by 15% at day 3 (9.5  0.11), by 21% at day
7 (8.9  0.27), and by 29% at day 14 (8.0  0.31) (P Z
0.002, days 3 and 7; P Z 0.0004, day 14) (Supplemental
Figure S8). Progressive segmental glomerular scarring and
synechial attachments (glomerular tuft adherent to Bow-
man’s capsule) increased relative to the baseline level (0.2
 0.013), reaching 0.5  0.04 at day 3, 1.0  0.05 at day 7,
and 1.2  0.15 at day 14 (P Z 0.0008, days 3 and 7; P Z
0.002, day 14) (Supplemental Figure S8). These data show
that Ren1cCreRs-ZsGreen-R mice developed character-
istic features of FSGS.
Experimental FSGS in Ren1cCreRs-ZsGreen-R Mice Is
Accompanied by an Increase in Cells of Renin Lineage
in Diseased Glomeruli
In Ren1cCreRs-ZsGreen-R mice, cells of renin lineage
labeled with ZsGreen in the JGC (Figure 5 and
Supplemental Figure S9), as expected. In normal adult
reporter mice, ZsGreen-labeled cells were detected in
20  1.98% of glomeruli at day 0 (baseline) (Figure 5). To548determine whether this effect was due to age, younger
mice were also studied. The percentage of glomeruli in
which ZsGreen-labeled cells were detected was similar in
younger mice (aged 7 or 28 days) and older mice (P >
0.05), which indicates that reporter labeling occurs early
in development. In diseased Ren1cCreRs-ZsGreen-R
mice, however, the percentage of glomeruli expressing at
least one ZsGreen-labeled cell increased progressively,
relative to baseline: 51  4.2% at day 3 (PZ 0.004), 59 
3.8% at day l7 (P Z 0.007), and 61  5.4% at day 14
(P Z 0.009) (Figure 5).
To determine the location of labeled cells of renin
lineage within glomeruli, the number of ZsGreen cells
within the glomerular tuft and lining Bowman’s capsule
was quantiﬁed (Figure 5). ZsGreen-labeled cells lining
Bowman’s capsule per glomerular cross section increased
in disease from 0.08  0.03 at baseline (day 0) to 0.49 
0.15 at day 3 (P Z 0.03), 0.35  0.03 at day 7 (P Z
0.003), and 0.27  0.06 at day 14 (P Z 0.002). The
number of ZsGreen-labeled cells detected in the glomer-
ular tuft increased from 0.45  0.05 at day 0 to 1.09 
0.25 at day 3 (P Z 0.03), 1.23  0.14 at day 7 (P Z
0.001), and 1.5  0.12 at day 14 (P Z 0.04) (Figure 5).
Within individual glomeruli, there was no particular
temporal preference for location within the glomerulus. As
expected, ZsGreen labeling was not detected in kidneys of
Ren1cCreRs-ZsGreen-R reporter mice devoid of Cre
(used as negative control; data not shown).
To establish that the detection of labeled cells of
renin lineage in glomeruli was not due to de novo renin
protein expression in Ren1cCreRs-ZsGreen-R mice,
double-staining was performed for ZsGreen and renin
(Supplemental Figure S9). In both normal and diseased
mice, renin immunostaining was restricted to cells in the
characteristic JGC location. In the majority of these cells,
renin staining overlapped with staining of ZsGreen-labeled
cells of renin linage. Although ZsGreen cells were detec-
ted in a subset of glomeruli, renin staining was absent in all
glomeruli of both normal and diseased mice. This was not
a false negative, because cells in the adjacent JGC stained
positive for renin.
Cells of Renin Lineage within Glomeruli of
Ren1cCreRs-ZsGreen-R Mice with Experimental FSGS
Express Proteins Considered Speciﬁc to Podocytes and
PECs
We next determined whether the cells of renin lineage
detected within the glomerular tuft of Ren1cCreRs-
ZsGreen-R mice express the podocyte proteins WT-1 and
synaptopodin. In induction of experimental FSGS, a subset
of ZsGreen-labeled cells within the glomerular tuft coex-
pressed WT-1 (Figure 6, AeC). The number of cells posi-
tive for both ZsGreen and WT-1 represented 64  11%
of the ZsGreen-positive cells in the glomerular tuft at day
14 of disease (0.89  0.14 double-positive cells perajp.amjpathol.org - The American Journal of Pathology
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baseline; P Z 0.007).
At day 14 of disease, the number of ZsGreen-labeled
cells that coexpressed synaptopodin increased signiﬁcantly
(0.72  0.11 double-positive cells per glomerular cross
section versus 0.38  0.09 at baseline; P Z 0.038)
(Figure 6, DeF); within the glomerular tuft, 89  2% of the
ZsGreen-labeled cells coexpressed synaptopodin at day 14
of disease. WT-1 and synaptopodin staining were absent
when the primary antibodies were omitted (data not shown),
and ZsGreen labeling was not detected in the Cre-negative
control mice (data not shown).
Taken together, these data show that when genetically
labeled cells of renin lineage move from the JGC to
the glomerular tuft in Ren1cCreRs-ZsGreen-R mice
with experimental FSGS, they express the podocyte proteins
WT-1 and synaptopodin, and they do not express renin
de novo.The American Journal of Pathology - ajp.amjpathol.orgWe next determined whether cells of renin lineage stain for
proteins expressed by PECs in diseased Ren1cCre
Rs-ZsGreen-R mice by double-staining for ZsGreen with
PAX2 or claudin-1 (Figure 7). The number of cells double-
positive for ZsGreen and PAX2 cells increased signiﬁcantly
along Bowman’s capsule at day 14 of disease (0.6  0.06
double-positive cells per glomerular cross section versus 0.18
 0.03 at baseline; PZ 0.0006). The number of cells double-
positive for ZsGreen and claudin-1 increased more than
twofold at day 14 (0.56  0.13 double-positive cells per
glomerular cross section versus 0.24  0.03 at baseline; PZ
0.0048). These ﬁndings indicate that, although at baseline
occasional cells stained for both PAX2 and claudin-1 in
Ren1cCreRs-ZsGreen-R mice, the number of double-
positive cells increased signiﬁcantly in disease. Taken
together, these data show that in Ren1cCreRs-ZsGreen-R
mice with disease, labeled cells of renin lineage lining Bow-
man’s capsule increase expression of the PEC proteins PAX2
and claudin-1.
Experimental FSGS in Ren1dCreZ/EG Mice
To further validate the ﬁndings, experimental FSGS was
induced in a third renin cell lineage reporter strain,
Ren1dCreZ/EG, in which cells of renin lineage are
Figure 5 Cells of renin lineage increase in glomeruli of Ren1cCreRs-
ZsGreen-R mice with experimental FSGS. Experimental disease was induced
in Ren1cCreRs-ZsGreen-R mice to fate-map cells of renin lineage with
ZsGreen reporter. No antibody was required to visualize ZsGreen, which
stains green in both cytoplasm and nucleus; DAPI was used to counterstain
nuclei blue. A and B: Representative ZsGreen labeling at baseline day 0. A:
Low-power view of ﬁve glomeruli (circles). ZsGreen ﬂuorescence is detected
in cells within the JGC (arrows) alongside three of the glomeruli; only one
cell is detected within a glomerulus (dashed arrow). B: A higher magniﬁ-
cation view of the boxed region in panel A shows that the ZsGreen ﬂuo-
rescence (arrow) was conﬁned to cells within the JGC. CeF: Representative
ZsGreen labeling at day 14 of disease. C: Low-power view of four glomeruli
(circles). The two glomeruli on the upper left are devoid of ZsGreen-labeled
cells. The glomerulus on the upper right has several ZsGreen-labeled cells,
which were predominantly located within the glomerular tuft (dashed
arrows). In the circled glomerulus within the boxed region, ZsGreen-
labeled cells are predominantly lining Bowman’s capsule (thin arrows),
but also appear in the JGC (thick arrow). D: A higher magniﬁcation view of
the boxed region in panel C more clearly shows the ZsGreen-labeled cells
lining Bowman’s capsule (arrows). E: At day 14, one glomerulus (left circle)
had no ZsGreen-labeled cells, but was accompanied by ZsGreen-labeled cells
in the JGC (thick arrow) and in blood vessels (dotted arrows). Another
glomerulus (right circle) had several ZsGreen-labeled cells (dashed arrows).
F: A higher magniﬁcation view of the boxed region in panel E shows the
ZsGreen-labeled cells as within the glomerular tuft (dashed arrows). G:
Quantiﬁcation of the number of ZsGreen-labeled cells. ZsGreen-positive cells
lining Bowman’s capsule (circles) were rarely detected at baseline (day 0).
In disease, however, the numbers of these cells were signiﬁcantly increased
at all time points, relative to baseline. The number of ZsGreen-positive cells
within the glomerular tuft (squares) had more than doubled at day 3, and
continued to increase signiﬁcantly at days 7 and 14. These data show an
increase in the number of cells of renin lineage in glomeruli of mice with
experimental FSGS. Labeled cells were detected either along Bowman’s
capsule, within the glomerular tuft, or at both locations. Data are expressed
as means  SEM. *P Z 0.03, yPZ 0.001, zPZ 0.04 versus d0 Bowman’s
capsule; xPZ 0.03, {PZ 0.003, kPZ 0.002 versus d0 glomerular tuft.
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Figure 6 In Ren1cCreRs-ZsGreen-R mice with experimental FSGS, cells
of renin in glomeruli costain for podocyte proteins. To determine whether
the cells of renin lineage express proteins considered to be podocyte
speciﬁc, experimental FSGS was induced in Ren1cCreRs-ZsGreen-R mice;
confocal microscopy was performed after staining for WT-1 or synaptopodin
(used as podocyte markers). ZsGreen ﬂuorescence, used to fate-map cells of
renin lineage, does not require antibody detection. AeC: Double-staining
for ZsGreen and WT-1. A: In a representative glomerulus at baseline (day
0), ZsGreen-labeled cells were detected outside the glomerulus, in the JGC
(green; thick arrow); ZsGreen staining did not overlap with WT-1 staining
(red; thin arrows) within the glomerulus. B: At day 14 of disease, ZsGreen
ﬂuorescence was detected in the JGC (thick arrows) and also in a cell
within the glomerular tuft (dashed arrow), where it overlapped with WT-1,
appearing yellow. Nuclear staining for WT-1 alone (red; thin arrows). C: A
higher magniﬁcation view of the boxed region in panel B more clearly
shows the coexpression overlap of ZsGreen and WT-1 (yellow; dashed
arrow). DeF: Double-staining for ZsGreen and synaptopodin. D: At day 0,
ZsGreen ﬂuorescence was seen in the afferent arteriole (thick arrow);
ZsGreen staining did not overlap with synaptopodin staining (red; thin
arrows) in the adjoining glomerulus. E: At day 14, ZsGreen ﬂuorescence
was still seen in the afferent arteriole (thick arrow), and an overlap of
ZsGreen and synaptopodin staining (yellow; dashed arrows) was seen in
a cell within the glomerular tuft. F: A higher magniﬁcation view of the
boxed region in panel B more clearly shows the coexpression overlap of
ZsGreen and synaptopodin (dashed arrows). These representative examples
show that, in Ren1cCreRs-ZsGreen-R mice with experimental FSGS,
a subset of cells of renin lineage labeled by ZsGreen within the glomerulus
express the podocyte proteins WT-1 and synaptopodin.
Figure 7 In Ren1cCreRs-ZsGreen-R mice with experimental FSGS, cells
of renin lineage that have entered the glomerulus coexpress PEC proteins.
Experimental FSGS was induced in Ren1cCreRs-ZsGreen-R mice and
confocal microscopy was performed after staining with antibodies to PAX2
and claudin-1 (used as PEC markers). ZsGreen ﬂuorescence, used to fate-
map cells of renin lineage, does not require antibody detection. AeC:
Double-staining for ZsGreen and PAX2. A: In a representative glomerulus at
baseline (day 0), ZsGreen-labeled cells were detected in cells outside the
glomerulus in the JGC (green; thick arrow); within the glomerulus, ZsGreen
staining did not overlap with PAX2 staining (red; thin arrows). Red blood
cell autoﬂuorescence (light green) was noted in the glomerular tuft. B: At
day 14, in a subset of cells along Bowman’s capsule, ZsGreen staining
overlapped with PAX2 staining (yellow; thick arrows). In another subset,
ZsGreen-labeled cells lining Bowman’s capsule did not express PAX2
(dashed arrows), and for some PAX2-positive cells the staining did not
overlap with ZsGreen (thin arrow). C: A higher magniﬁcation view of the
boxed region in panel B more clearly shows the coexpression overlap of
ZsGreen and PAX2 staining (thick arrow), along with single PAX2 stain
(thin arrow). DeF: Double-staining for ZsGreen and claudin-1. D: At
baseline, ZsGreen ﬂuorescence in the afferent arteriole (thick arrow) did
not overlap with claudin-1 staining (red; thin arrows) in the adjoining
glomerulus. E: At day 14, in two cells lining Bowman’s capsule ZsGreen
staining overlapped with claudin-1 staining (yellow; thick arrows). One
ZsGreen-labeled cell lining Bowman’s capsule did not stain for claudin-1
(dashed arrow). F: A higher magniﬁcation view of the boxed region in
panel E more clearly shows the coexpression overlap of ZsGreen and
claudin-1 (arrows). These representative examples show that, in Ren1-
cCreRs-ZsGreen-R mice with experimental FSGS, a subset of cells of renin
lineage labeled by ZsGreen within the glomerulus express the PEC proteins
PAX2 and claudin-1 when these cells line Bowman’s capsule.
Pippin et algenetically labeled with GFP. Podocyte number, as measured
by p57 staining,50 decreased in Ren1dCreZ/EG mice
relative to baseline (10.6  0.43) by 25% after 7 days (7.9 
0.11; PZ 0.008) and by 34% after 14 days (7.0 0.17; PZ
0.0003) (Supplemental Figure S10). Mice also developed
progressive focal and segmental glomerular scarring with
synechial attachments: mean glomerulosclerosis grade of
1.2  0.04 at day 7 and 1.4  0.15 at day 14, versus
0.2  0.004 at baseline (PZ 0.0001, day 7; PZ 0.004, day
14) (Supplemental Figure S10). These data showed that
experimental FSGS was successfully induced in
Ren1dCreZ/EG mice, and that the extent of podocyte
loss and glomerular scarring was highest in this reporter
strain.550Cells of Renin Lineage Increase in Glomeruli of
Ren1dCreZ/EG Mice with Experimental FSGS
Cells of renin lineage are permanently labeled with GFP in
Ren1dCreZ/EG mice; these cells were not detected in the
kidneys of themicedevoidofCre used as negative controls, nor
if the primary antibody was omitted for GFP staining. At
baseline (day 0), only 5 1.3% of glomeruli contained one or
more GFP-labeled cell. In disease, the percentage of glomeruli
with GFP-labeled cells increased signiﬁcantly and progres-
sively, relative to baseline: 38 2% at day 7 (PZ 0.003) and
43  5% at day 14 (PZ 0.009) (Supplemental Figure S11).
As with the other reporter mice, renin staining was limited toajp.amjpathol.org - The American Journal of Pathology
Renin Lineage Cell and Glomerular Repairthe JGC, where it costained with GFP (data not shown). No
renin staining was detected in normal or diseased glomeruli.
In diseased mice, a progressive increase in GFP-labeled
cells along Bowman’s capsule was detected, relative to
baseline (0.03  0.02 GFP-labeled cells per glomerular cross
section): 0.74  0.22 at day 7 (PZ 0.05) and 1.8  0.08 at
day 14 (PZ 0.0006) (Supplemental Figure S11). The number
of GFP-labeled cells in the glomerular tuft also increased,
relative to zero at baseline: 0.1  0.0003 GFP-labeled cells
per glomerular cross section at day 7 (P < 0.05) and 0.4 
0.04 at day 14 (P Z 0.004) (Supplemental Figure S11).
Within individual glomeruli, GFP-labeled cells were detected
either along Bowman’s capsule, within the glomerular tuft, or
in both locations. There was no particular temporal preference
for location within a glomerulus. These data in Ren1dCreZ/
EG mice are consistent with labeled cells of renin lineage
having moved after the onset of experimental FSGS from the
JGC to the glomerular compartment, where they line Bow-
man’s capsule and the glomerular tuft.
Cells of Renin Lineage Express Glomerular Epithelial
Cell Proteins in Diseased Ren1dCreZ/EG Mice
At baseline in Ren1dCreZ/EG reporter mice, WT-1
staining was restricted to podocytes, and GFP labeling
was mainly restricted to cells of renin lineage in the JGC.
WT-1 and GFP staining did not overlap at baseline (zero
double-positive cells). In diseased Ren1dCreZ/EG mice,
occasional GFP-labeled cells double-stained for WT-1
(0.1  0.01 double-positive cells per glomerular cross
section; P < 0.05). By day 14, the number of cells coex-
pressing GFP and WT-1 in the glomerular tuft increased
signiﬁcantly (0.37  0.1; P Z 0.03). It is noteworthy that,
in the glomerular tuft, 95  2% of the GFP-labeled cells
coexpressed WT-1 by day 14.
No costaining for GFP and synaptopodin was detected in
the glomerular tuft at baseline. In experimental FSGS, GFP-
labeled cells in the glomerular tuft that coexpressed syn-
aptopodin increased slightly, relative to zero at baseline:
0.07  0.001 double-positive cells per glomerular cross
section at day 7 (PZ 0.08) and 0.27  0.01 at day 14 (PZ
0.005). In the glomerular tuft, 89  2% of GFP-labeled cells
coexpressed synaptopodin by day 14 of disease.
Although occasional GFP-labeled cells were detected in
less than 5% of glomeruli, none of them coexpressed PAX2
at baseline. In experimental FSGS, a subpopulation of cells
along Bowman’s capsule stained for both GFP and PAX2 at
both day 7 (0.45  0.03 double-positive cells per glomer-
ular cross section; PZ 0.05) and day 14 (0.55  0.13; PZ
0.03). Of the GFP-labeled cells lining Bowman’s capsule,
65  15% of GFP-labeled cells coexpressed PAX2 on day
7, which decreased to 31  7% on day 14 of disease. Thus,
a subpopulation of GFP-labeled cells lining Bowman’s
capsule did not express PAX2.
No cells costained for claudin-1 and GFP at baseline. The
number of GFP-labeled cells that coexpressed claudin-1The American Journal of Pathology - ajp.amjpathol.orgincreased signiﬁcantly in diseased mice at both day 7 (0.62 
0.06 double-positive cells per glomerular cross section;
P Z 0.008) and day 14 (0.81  0.1; P Z 0.005).
Taken together, these data show that, during experimental
FSGS in Ren1dCreZ/EG reporter mice, labeled cells of
renin lineage increase in number within glomeruli, where
they do not express renin but begin to express proteins
considered to be unique to both types of glomerular
epithelial cells (ie, both podocytes and PECs).
Cells of Renin Lineage Do Not Express Mesangial or
Glomerular Endothelial Cell Markers
Double-staining for cells of renin lineage with markers for
mesangial cells (PDGFR-b and type IV collagen) or endo-
thelial cells (MECA-32) did not increase in glomeruli in this
model (data not shown).
Cells of Renin Lineage Do Not Express Certain Stem Cell
Markers
Cells of renin lineage did not stain for CD24, CD44, or
CD133 in normal or diseased states (data not shown).
Renin Transcripts Are Not Detected in Diseased
Glomeruli
Expression of renin transcripts may not result in protein
expression. We therefore generated RenGFP transgenic
reporter mice using a BAC transgenic method similar to that
which drives mouse renin Cre (RenCre), in which a GFP
reporter is driven directly by the renin promoter and all its
regulatory elements in a 227-kb segment of chromosome
140 (Supplemental Figure S1). Any cell actively transcribing
renin mRNA will express GFP protein. At baseline, GFP
staining was readily detected, but restricted only to cells in
the JGC that precisely stained for renin protein
(Supplemental Figure S12). An average of 50 glomeruli
from each mouse were observed at days 14, 21, and 28 of
disease. No GFP or renin staining was detected within any
glomeruli of RenGFP mice with experimental FSGS
(Supplemental Figure S12). This indicates that the renin
promoter was not active in cells within the glomerulus
during disease (no mRNA transcribed) and also explains
why renin protein was not detected in diseased glomeruli
(Supplemental Figure S12). These data indicate that the
appearance of genetically labeled cells of renin lineage in
glomeruli during experimental FSGS is likely due to
migration of cells from the JGC into the glomerulus, and not
due to DNA recombination in injured glomerular cells
because of activation of the renin gene.
Discussion
The leading causes of progressive kidney disease with
proteinuria are diabetic nephropathy, FSGS, and551
Pippin et almembranous nephropathy. These glomerular diseases are
characterized by injury to glomerular podocytes. Injury-
induced apoptosis, necrosis, autophagy, and detachment
lead to progressive podocyte loss. Although many other
cells in the kidney are replaced after loss by proliferation of
surviving cells, total podocyte number per glomerulus
frequently decreases after loss, because of impaired capacity
of surviving podocytes to successfully undergo cell divi-
sion.11e17 Until recently, little has been understood about
the kinetics of podocyte turnover and attrition in chronic
disease.
Recent seminal studies have shed light on neighboring
glomerular PECs as a likely source of podocyte progenitors.
A subset of PECs near the tubular pole express progenitor
markers.27,32,67,68 In diseased states characterized by podo-
cyte injury, PECs can activate cellular protein markers
normally considered to be restricted to podocytes,27,29,30,68
and fate-mapping experiments suggest that PECs may
becomepodocytes duringpostnatal kidneygrowth.24Although
still speculative, theseﬁndings suggest that PECsmay subsume
some of the functions ascribed to podocytes, particularly in
response to disease. At present, however, it remains unclear
whether there is a common pool of precursor cells that can
replenish podocytes and PECs, and whether replacement of
podocytes by PECs is reparative or is, alternatively, part of an
ongoing process of injury. The present results indicate that cells
of renin lineage have the capacity to serve as progenitors for
both PECs and podocytes in an experimental model charac-
terized by reduced podocyte number.
The central approach used in the present studies was
genetic fate mapping of cells of renin lineage in three newly
generated and one existing reporter transgenic mouse strain.
The advantage of the newly developed Ren1cCreERRs-
tdTomato-R mouse is that a cohort of cells of renin lineage
is genetically labeled with tomato red protein in an inducible
manner only during the speciﬁc time period when the mice
are given tamoxifen. This enables deﬁnitive and permanent
cell fate mapping by measuring RFP. In contrast, the newly
developed Ren1cCreRs-ZsGreen-R and the previously
reported Ren1dCreZ/EG mice rely on constitutive reporter
systems; thus, the entire complement of cells that express
renin during ontogeny permanently express ZsGreen and
GFP in the two strains, respectively, including both cells of
renin lineage and cells derived from their lineage. In the
newly developed RenGFP mice, GFP labels cells in which
renin mRNA is actively being transcribed.
Renin Lineage Cells Exist at Different Numbers within
the Glomerulus at Baseline
The ﬁrst major ﬁnding in the present study was a differential
number of labeled cells of renin lineage in the glomeruli of
normal baseline reporter mice (ie, before disease induction).
In baseline adult Ren1cCreERRs-tdTomato-R mice given
tamoxifen, RFP was not detected in any glomeruli. In
baseline Ren1dCreZ/EG and Ren1cCreRs-ZsGreen-R552mice, however, less than 5% of glomeruli expressed at least
one GFP-labeled cell and less than 20% of glomeruli
expressed at least one ZsGreen-labeled cell. Several expla-
nations are possible for the differences between transgenic
strains in the number of labeled cells within the glomerulus
at baseline. First, by administering tamoxifen in normal
Ren1cCreERRs-tdTomato-R adult mice (well before
injury induction), we ensured that only cells in the JGC
were labeled. The more extensive preglomerular vascular
wall population that expresses renin during renal ontogeny
and is captured by RenCre were therefore not marked in this
strain, although they are marked are in Ren1dCreZ/EG
and Ren1cCreRs-ZsGreen-R mice.
Another possible explanation is that the two reporter
systems use highly similar but distinct promoters, Ren1d and
Ren1c, to drive Cre expression. Prior assessments of Ren1c
and Ren1d expression suggest that the genes exhibit distinct,
but highly overlapping, tissue-speciﬁc and developmental
expression patterns. The Ren1d allele is found in association
with another renin gene locus, Ren2. We developed a meth-
odology for distinguishing the highly similar transcripts
generated by the individual alleles at the Ren1 locus or at the
Ren1 and Ren2 loci.69 Ren1c was observed to accumulate in
normal kidney to twice the steady-state level of Ren1d in F1
animals (hybrids of the one- and two-locus strains), and
Ren1d was observed to accumulate to slightly higher levels
than Ren2 in kidney.69 The latter result was also observed by
Smithies and colleagues.70 The best available evidence from
all investigators suggests that, in normal animals, all three
transcripts are localized to similar cells in kidney. More
marked, gene-speciﬁc variation in expression is observed in
other tissues.69 We used both strains because they differ in
allelic reporting potential and also in other important char-
acteristics. The Ren1dCre strain is constructed by gene tar-
geting on a two-renin-locus strain background. It is normally
used as a heterozygote, to avoid disruption of both alleles at
the Ren locus. Although Ren2 can compensate for homozy-
gous loss of Ren1d as regards observable renal pathology,
there is presumably diminished output from the Ren1d
promoter and unknown drive as regards compensatory cell
recruitment.70 The Ren1cCre strain was constructed by
homologously recombining the Cre cassette in phase with the
Ren1c promoter within a large 227-kb C57BL/6 BAC and
constructing transgenic mice. In consequence, the Ren gene
is surrounded by a large normal ﬂanking chromosome
environment, but there is no compromising of expression
from the endogenous Ren loci. In effect, it is more of
a reporter. We submit that at this juncture it remains to be
elucidated whether we are dealing with variable fate sorting
during normal development or possibly even in response to
reparative action during normal development. It is quite
conceivable that relative sensitivity or compensatory drive
also come into play. What is more important at this point, in
our opinion, is that the different types of Cre constructs are
reporting similar results qualitatively, albeit not identical
results quantitatively. Most importantly, some of these issuesajp.amjpathol.org - The American Journal of Pathology
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of sensitivity, the entire history of expression during kidney
development, whereas the RenCreERt2 construct permits
capturing the response of a potentially more restricted jux-
taglomerular population from adult animals.
As a third explanation, it is possible that the ﬂoxed
ZsGreen reporter is more sensitive in response or intensity
of expression, facilitating earlier or more robust detection.
Fourth, it is also conceivable that any natural replacement
being reported is highly stochastic between individual mice,
or is inﬂuenced by environmental differences in vivarium
conditions. Finally, to explore the possibility that the
number of labeled cells might reﬂect age differences in
Ren1cCreRs-ZsGreen-R mice, we also studied young
mice, during the ﬁnal phase of kidney development (1 week
of age) and in adolescence (4 weeks), and compared these to
mature mice (>10 weeks). The number of glomerular cells
expressing ZsGreen label were similar across all time points,
suggesting that labeled cells were normally present in
glomeruli starting at a young age and thus are not a function
of age per se. The fact that the adolescent and mature
patterns were similar suggests that the observed events arise
early. These results support the ﬁndings of Gomez and
colleagues,34 who detected the presence of cells of renin
lineage in adult Ren1dCreZ/EG mice. This is consistent
with our observation that the Ren1cCreERRs-tdTomato-R
reporter had a zero baseline level. It is noteworthy that that
renin cells are very few in number, and account for only
0.01% to 0.001% of the total kidney cell mass.34
Numbers of Renin Lineage Cells Increase in Glomeruli
after Disease
A second major ﬁnding from the present study is that geneti-
cally fate-mapped cells of renin lineage were detected in
signiﬁcantly more glomeruli of all three reporter mouse strains
after the development of experimental FSGS. An increase in
labeled cells was detected as early as day 3 of disease in
Ren1cCreRs-ZsGreen-R mice. In this strain, and also in the
Ren1dCreZ/EGmice, therewas a progressive and signiﬁcant
increase in number of fate-mapped cells of renin lineage at
each time point. It is noteworthy that the number of labeled
cells in the glomerulus temporally correlated with a progres-
sive decline in podocyte number during disease. We have
previously reported that the model used in these studies has
many features characteristic of clinical FSGS (ie, reduced
podocyte number, proteinuria, and glomerulosclerosis).30,45,46
One explanation for the differences in the absolute numbers of
labeled cells in the glomeruli of the three different reporters
with disease is that, despite similar deposition of disease-
inducing cytotoxic anti-podocyte antibody, the intensity of
disease differed by strain. It is not surprising, therefore, that the
number of cells of renin lineage detected in glomeruli differ by
strain. Because Ren1cCreERRs-tdTomato-R mice were
given tamoxifen only on three occasions during their sixth
week of life, one possible explanation for their relatively lowerThe American Journal of Pathology - ajp.amjpathol.orgnumber of labeled cells in disease glomeruli, compared with
the constitutive reporter strains, is that the reservoir or pool of
labeled cells of renin lineage was simply insufﬁcient to capture
the magnitude of cells that might enter the glomerulus from
generations before or after the labeling process. Although cells
of renin lineage were detected both lining Bowman’s capsule
and within the glomerular tuft, there was no obvious pattern,
either temporally or spatially, of labeled cells in individual
glomeruli. Noteworthy is the location of cells of renin lineage
within glomeruli. Romagnani and colleagues27,68 have
elegantly shown that a subpopulation of PECs that serve as
progenitors are located predominantly at the tubular pole. Cells
of renin lineage appear to enter the glomerulus at the vascular
pole, but thereafter are not restricted in location.
Renin Lineage Cells Express Markers of Glomerular
Epithelial Cells
The third major ﬁnding in the present study was that, on
entering the glomerulus, a subset of cells of renin lineage
begins to express proteins considered to be speciﬁc for
glomerular epithelial cells (ie, podocytes and PECs).
In diseased Ren1cCreERRs-tdTomato-R, Ren1cCreRs-
ZsGreen-R, and Ren1dCreZ/EG mice, a signiﬁcant
subpopulation of labeled cells in the glomerular tuft coex-
pressed WT-1, nephrin, podocin, or synaptopodin, which are
consideredmarkers of podocytes.Additionally, after the onset
of experimental FSGS in all three reporter mice, a signiﬁcant
subpopulation of labeled cells lining the Bowman’s capsule,
coexpressed PAX2 or claudin-1, both considered markers of
PECs. There was no obvious pattern of cells of renin lineage
expressing either podocyte or PEC markers.
One might ask whether the numbers of labeled cells
expressing either podocyte or PEC proteins is a meaningful
measure. In this model, the decrease in podocyte number after
the onset of disease was typically three to four cells per
glomerular cross section. Also, labeled cells were found in
0% to 20% of glomeruli before disease induction in the
constitutive reporter mice, and this increased to between 41%
and 61% of glomeruli after disease induction (P < 0.001).
These data give an indication of how many glomeruli con-
tained positive cells. The mean number of labeled cells per
glomerular cross section was also quantiﬁed. An average of
76 glomeruli were counted, so on average this results in
between 0.3 and 0.63 cells along Bowman’s capsule per
glomerular cross section and 0.1 to 1.71 cells within the
glomerular tuft per glomerular cross section after disease.
Because FSGS is a focal disease, it is not surprising that
many glomeruli have no labeled cells, some have only a few,
and some have many. Finally, glomerular cross sections were
analyzed, rather than the three-dimensional structure of the
entire glomerulus; the latter would of course enhance the
overall number of labeled cells. It is noteworthy that,
although some have reported that PEC progenitors appear
evident predominantly at the tubular pole,68 others report
them at the vascular pole.24,28 It is not an anomaly, therefore,553
Pippin et althat our studies show the cells of renin lineage deriving from
the vascular pole.
Several lines of evidence in the present study indicate that
the detection of cells of renin lineage within glomeruli does
not represent false positives simply due to the expression or
re-expression of renin protein and/or mRNA. First, in
Ren1cCreERRs-tdTomato-R reporter mice, cells of renin
lineage are labeled only after the administration of tamoxifen.
Also, tamoxifen was withdrawn well before disease induc-
tion, and therefore all glomerular-associated reporting is
attributable only to pre-existing tdTomato Redelabeled cells
(exclusively of juxtaglomerular origin) in this reporter
mouse. These cells may later change phenotype, migrate, or
divide, but they will have initially arisen as cells of renin
lineage from the JGC. Second, no immunostaining with an
antibody recognizing renin and prorenin was detected in any
glomeruli in any of the four reporters at any time in health or
disease; rather, such immunostaining was conﬁned entirely to
the JGC. Third, double-staining for each reporter (RFP,
ZsGreen, and GFP) with renin showed coexpression only in
the JGC, not in glomeruli. Fourth, we used a RenGFP reporter
mouse, which we generated speciﬁcally to report contem-
poraneous renin promoter activity by GFP expression. As
expected, renin mRNA was restricted to cells of the JGC that
stained for renin. Finally, another point to keep in mind when
looking at RenCre lineage in glomeruli is that cells of renin
lineage could arise from other than the JGC (eg, cells from
larger arterioles). Moreover, we know that RenCre is
expressed in other locations, such as bone marrow (B cells),
and thus one could argue that these cells are inﬁltrating the
glomerulus. The Ren1cCreERRs-tdTomato-R experiments
makes for a slightly cleaner model with regard to kidney
reporting, but one that is not necessarily infallible with regard
to bone marrow inﬁltrate. Taken together, these data show
that the genetic cell fate-mapping approach to studying cells
of renin lineage in experimental FSGS is accurate and the
ﬁndings are not due to de novo expression or re-expression of
renin mRNA or protein, nor are they an artifact of the Cre
system used.
Conclusions
Our ﬁndings suggest a number of critical implications.
Renin-producing cells of the juxtaglomerulus are modiﬁed
smooth muscle cells at the tip of the afferent arteriole
supplying the glomerulus; they are derived from meta-
nephric mesenchyme fated to become kidney stroma, not
epithelium. Our data show that, under the conditions
studied, podocytes and PECs might originate from cells of
renin lineage, a ﬁnding that could shed light on novel
functions previously not considered. Because podocytes and
PECs exhibit structural and molecular features similar to
epithelial cells, glomerular cells derived de novo from cells
of renin lineage may be functionally discrete from the
glomerular cells. These studies also beg the question of
whether a low-level replacement of podocytes and PECs,554from cells of renin lineage, occurs in homeostasis. Although
it has been assumed that the podocyte population is not
replenished, it is more likely that a cell so critical to survival
can somehow be replaced. Thus, it is quite possible that
podocytes are steadily replenished throughout life. Our
ﬁndings also raise critical questions about whether PECs are
an intermediate for podocytes that arise from cells of renin
lineage and whether PECs not derived from cells of renin
lineage can also become podocytes. The present studies
were not designed to determine whether cells of renin
lineage ﬁrst become differentiated PECs and subsequently
become podocytes; further detailed fate mapping would be
required to ascertain this sequence.
We have reﬂected a great deal on the movement of cells of
renin lineage from their juxtaglomerular origin to the
glomerulus, which likely includes the crossing of either the
parietal and/or the glomerular basement membrane.
Although we did not perform formal migration studies, we
believe that such migration is entirely possible, based on
literature supporting the notion that cells routinely cross
basement membranes.71e75 A minor population of renin
lineage cells are pericytes of the peritubular capillaries and
are migratory. Vascular smooth muscle cells in other arteri-
oles have been shown to migrate from the vessel wall to the
adventitia and back, breaching membranes and, in artery
walls, vascular smooth muscle cells have been shown to
migrate to cover atheromatous plaque, which also involves
breaching membranes. It is therefore likely that these cells
can pass through membranes. Also, when epithelial-derived
tumors metastasize, the ﬁrst barrier that invading cells
breach is the basement membrane underlying the epithelium.
Freed cells then traverse the stromal connective tissue,
a gelatinous extracellular matrix rich in proteoglycans that
surrounds glands and blood vessels, and then again cross
the basement membranes of blood or lymphatic vessels to
disperse into these vessels. During extravasation, the inva-
sive cells cross back through the vascular basement
membrane into new tissues where they can form micro-
metastases.71 Other examples include cells routinely crossing
basement membranes during normal development and cells
crossing membrane to perform immune-system functions.
Moreover, red blood cells have been shown by transmission
electron microscope to cross the glomerular basement
membrane in thin basement membrane nephropathy72 and in
minimal change disease.73 Podocytes have been shown by
multiphoton excitation ﬂuorescence microscopy to cross
Bowman’s capsule.74 Finally, careful examination of pub-
lished reports of transmission electron microscope studies
reveals that the structure of the area where the afferent arte-
riole, Bowman’s capsule, and glomerular basement
membrane converge is highly layered (many thin layers of
basement membrane), rather than a single thick layer.75 The
layering likely enables cells to get across. Taken together,
these various studies suggest that cells of renin lineage
crossing one or more membranes to get to the glomerulus is
a physiologically plausible notion.ajp.amjpathol.org - The American Journal of Pathology
Renin Lineage Cell and Glomerular RepairAlthough the present studies provide evidence for new
podocytes and PECs arising from cells of renin lineage,
functional data are lacking. The critical functions of podo-
cytes are to maintain the slit diaphragm, maintain the
glomerular basement membrane, and to maintain endothelial
cell integrity. Further studies would be required to determine
whether podocytes derived from cells of renin lineage can
perform these critical tasks. Currently, the molecular
programs that generate podocytes are poorly understood. We
were unable to detect a limited number of stem cell and
progenitor cell markers (CD24, CD44, and CD133) in cells
of renin lineage during disease. This of course does not rule
out stemness, given the large number of potential markers
that might be considered. Further studies are needed to
dissect the transcriptional program for the differentiation of
cells of renin lineage into podocytes and PECs.
Our data in the present study strongly support the
notion that, in this experimental disease model of FSGS, cells
of renin lineage do not likely give rise to mesangial
and glomerular endothelial cells. The availability of models of
podocyte disease is limited in mice, being restricted by strain
and sex, among other determinants.76 Our present model relies
on an antibody that recognizes one or more as yet unidentiﬁed
podocyte antigens. However, as we have reported for several
other transgenic mouse strains,30,45,46 the antibody reliably
reduces podocyte number, which leads to segmental glomer-
ular scarring in less than half of all glomeruli and to synechial
attachment in approximately 30% to 35% of glomeruli. These
ﬁndings resemble classic clinical FSGS, and therefore the
model was appropriate for the purposes of the present study.
This model is distinct from other models in mice induced by
anti-glomerular antibodies leading to pseudo-crescents.13,47e50
Because cells of renin lineage no longer express renin in the
glomerulus during disease, this limits validation in other rodent
models or in human disease until such time as a speciﬁc cell of
renin lineage marker is identiﬁed. Additional experimental
models in reporter mice are needed. It is unclear why cells of
renin lineage no longer express renin. Reports indicate that
WT-1 can regulate renin,77 but further studies are needed to
determine the events involved. The lack of renin staining does
provide a challenge for studies in nonreporter mice and until
such time as another marker of cells of renin lineage can be
identiﬁed.
In summary, we propose the emergence of a novel
paradigm in which cells of renin lineage serve as progenitor
cells for both glomerular PECs and podocytes in experi-
mental glomerular disease. We suggest that further study
and exploration are merited.Acknowledgments
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